https://curecurrent.com/trials/evaluating-the-user-performance-and-experience-of-nucleus-pen-vs-commercially-available-pen-needle-4808 https://curecurrent.com/trials/gestational-diabetes-mellitus-trial-gdm-4809 https://curecurrent.com/trials/the-feasibility-of-a-diet-and-exercise-intervention-in-diabetics-during-treatment-for-non-muscle-invasive-bladder-cancer-4810 https://curecurrent.com/trials/extension-to-study-200952-to-evaluate-the-long-term-safety-tolerability-and-pharmacodynamics-of-albiglutide-liquid-drug-4811 https://curecurrent.com/trials/diabetes-dietary-study-low-carbohydrate-and-low-fat-diets-in-type-2-diabetes-4812 https://curecurrent.com/trials/technologically-enhanced-coaching-a-program-to-improve-diabetes-outcomes-4813 https://curecurrent.com/trials/a-new-wizard-for-insulin-sensitivity-estimation-from-sap-a-randomized-controlled-trial-in-adolescents-with-t1d-4814 https://curecurrent.com/trials/effect-of-bariatric-surgery-on-mechanisms-of-type-2-diabetes-4815 https://curecurrent.com/trials/growth-hormone-feedback-to-insulin-like-growth-factor-i-igf-1-and-oral-glucose-tolerance-test-ogtt-4816 https://curecurrent.com/trials/an-observational-pilot-study-to-develop-a-behavioral-economics-electronic-health-record-module-to-guide-the-care-of-olde-4817 https://curecurrent.com/trials/non-healing-diabetic-foot-ulcers-dfu-treated-with-soc-with-or-without-neox-cord-1k-4818 https://curecurrent.com/trials/trial-to-evaluate-cardiovascular-and-other-long-term-outcomes-with-semaglutide-in-subjects-with-type-2-diabetes-4819 https://curecurrent.com/trials/enhancement-of-cerebral-vasoreactivity-and-cognition-by-intranasal-insulin-in-type-2-diabetes-4820 https://curecurrent.com/trials/multi-center-site-controlled-trial-comparing-a-bioengineered-skin-substitute-to-a-human-skin-allograft-4821 https://curecurrent.com/trials/digital-self-management-program-for-medicare-advantage-members-with-type-2-diabetes-impact-on-a1c-4822 https://curecurrent.com/trials/statins-in-children-with-type-1-diabetes-and-hypercholesterolemia-4823 https://curecurrent.com/trials/effect-of-cycloset-on-glycemic-control-when-added-to-glucagon-like-peptide-1-glp-1-analogue-therapy-4824 https://curecurrent.com/trials/family-model-of-diabetes-self-management-education-in-the-marshallese-community-4825 https://curecurrent.com/trials/exenatide-inpatient-trial-a-randomized-controlled-pilot-trial-on-the-safety-and-efficacy-of-exenatide-byetta-therapy-for-4826 https://curecurrent.com/trials/changing-healthy-outcomes-in-clinic-environments-4827 https://curecurrent.com/trials/hispanic-secondary-stroke-prevention-initiative-4828 https://curecurrent.com/trials/assessing-home-food-environment-and-diabetes-self-management-among-adult-type-2-diabetes-patients-4829 https://curecurrent.com/trials/the-va-diabetes-trial-follow-up-study-vadt-fs-4830 https://curecurrent.com/trials/point-of-care-health-literacy-and-activation-information-to-improve-diabetes-care-4831 https://curecurrent.com/trials/targeted-enteral-nutrient-delivery-a-prospective-randomized-study-4832 https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-pediatric-accuracy-study-4833 https://curecurrent.com/trials/effect-of-occupational-therapy-in-promoting-medication-adherence-4834 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-study-of-egt0001474-in-subjects-with-type-2-diabetes-4835 https://curecurrent.com/trials/a-trial-investigating-the-efficacy-and-safety-of-insulin-degludec-in-children-and-adolescents-with-type-1-diabetes-melli-4836 https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-insulin-glargine-once-daily-as-add-on-to-metformin-with-or-without-4837 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-thr-149-in-subjects-with-diabetic-macular-edema-dme-4838 https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-exenatide-er-2-0-mg-once-weekly-as-add-on-to-1-2-oral-antidiabetic-4839 https://curecurrent.com/trials/parent-mentors-to-improve-adherence-to-type-i-diabetes-care-regimen-in-adolescents-4840 https://curecurrent.com/trials/efficacy-and-safety-of-faster-acting-insulin-aspart-compared-to-novorapid-both-in-combination-with-insulin-degludec-in-a-4841 https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-placebo-in-drug-na-ve-subjects-with-type-2-diabetes-4842 https://curecurrent.com/trials/efficacy-and-safety-of-fiasp-in-a-basal-bolus-regimen-versus-basal-insulin-therapy-both-in-combination-with-metformin-in-4843 https://curecurrent.com/trials/latinos-understanding-the-need-for-adherence-in-diabetes-4844 https://curecurrent.com/trials/efficacy-and-safety-of-fiasp-compared-to-insulin-aspart-both-in-combination-with-insulin-detemir-in-adults-with-type-1-d-4845 https://curecurrent.com/trials/a-trial-investigating-the-efficacy-and-safety-of-insulin-degludec-insulin-aspart-once-daily-plus-insulin-aspart-for-the-4846 https://curecurrent.com/trials/dapagliflozin-and-metformin-alone-and-in-combination-in-overweight-obese-prior-gdm-women-4847 https://curecurrent.com/trials/iomit-reducing-intentional-insulin-misuse-in-type-1-diabetes-4848 https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-placebo-as-add-on-to-basal-insulin-alone-or-basal-insulin-in-combi-4849 https://curecurrent.com/trials/study-to-determine-the-safety-tolerability-and-pharmacokinetic-pk-profile-of-egt0001474-in-healthy-volunteers-4850 https://curecurrent.com/trials/tele-pharmacy-intervention-to-improve-treatment-adherence-4851 https://curecurrent.com/trials/effect-of-liraglutide-on-epicardial-fat-in-subjects-with-type-2-diabetes-4852 https://curecurrent.com/trials/promotora-led-intervention-for-metabolic-and-mental-health-4853 https://curecurrent.com/trials/efficacy-and-safety-of-faster-acting-insulin-aspart-compared-to-novorapid-both-in-combination-with-insulin-degludec-in-c-4854 https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-4855 https://curecurrent.com/trials/evaluation-of-an-ascensia-diabetes-care-blood-glucose-meter-and-app-system-4856 https://curecurrent.com/trials/physiologic-insulin-therapy-for-the-management-of-hyperglycemia-in-the-hospital-4857 https://curecurrent.com/trials/adolescent-self-care-and-knowledge-education-in-diabetes-improved-by-texting-4858 https://curecurrent.com/trials/islet-cell-transplants-for-diabetes-4859 https://curecurrent.com/trials/nutraceutical-citrulline-in-pregnancy-4860 https://curecurrent.com/trials/vascular-impairment-in-type-ii-diabetes-mellitus-with-co-morbid-obstructive-sleep-apnea-4861 https://curecurrent.com/trials/continuous-glucose-monitors-to-regulate-glucose-levels-in-type-2-diabetics-4862 https://curecurrent.com/trials/avert-shock-arginine-vasopressin-during-the-early-resuscitation-of-traumatic-shock-4863 https://curecurrent.com/trials/the-use-of-magnesium-to-improve-blood-pressure-cholesterol-and-glucose-control-4864 https://curecurrent.com/trials/trial-to-evaluate-the-effect-of-aln-pcssc-treatment-on-low-density-lipoprotein-cholesterol-ldl-c-4865 https://curecurrent.com/trials/dosing-study-of-ranibizumab-for-diabetic-retinal-and-macular-edema-4866 https://curecurrent.com/trials/evaluation-of-vler-indiana-health-information-exchange-demonstration-project-4867 https://curecurrent.com/trials/personalized-smartphone-assisted-coaching-system-to-improve-glucose-homeostasis-in-adults-with-prediabetes-main-study-4868 https://curecurrent.com/trials/clinical-benefits-of-a-blood-glucose-monitoring-system-in-patients-with-type-2-diabetes-4869 https://curecurrent.com/trials/study-of-st266-in-diabetic-subjects-with-deep-burns-managed-with-skin-grafts-4870 https://curecurrent.com/trials/regulation-of-postprandial-nitric-oxide-bioavailability-and-vascular-function-by-dairy-milk-4871 https://curecurrent.com/trials/peak-plantar-pressures-while-wearing-a-carbon-fiber-off-loading-orthoses-4872 https://curecurrent.com/trials/a-trial-comparing-the-safety-and-efficacy-of-insulin-degludec-and-insulin-glargine-with-or-without-oads-in-subjects-with-4873 https://curecurrent.com/trials/a-6-month-clinical-study-to-evaluate-the-effect-of-a-digital-disease-management-tool-in-patients-with-t2dm-4874 https://curecurrent.com/trials/ursodiol-on-insulin-sensitivity-gastric-emptying-and-body-weight-with-type-2-diabetes-on-metformin-4875 https://curecurrent.com/trials/cadence-and-intensity-in-adults-with-type-2-diabetes-4876 https://curecurrent.com/trials/atrasentan-spermatogenesis-and-testicular-function-4877 https://curecurrent.com/trials/real-world-glycemic-effectiveness-of-linagliptin-4878 https://curecurrent.com/trials/cardioprotective-activities-of-whole-eggs-on-vascular-endothelial-function-in-prediabetic-adults-4879 https://curecurrent.com/trials/building-a-healthy-temple-a-diabetes-self-management-support-program-in-hispanic-faith-community-settings-4880 https://curecurrent.com/trials/role-of-methane-in-glycemic-control-4881 https://curecurrent.com/trials/milk-protein-feeding-after-aerobic-exercise-in-older-adults-with-pre-diabetes-taking-the-biguanide-metformin-4882 https://curecurrent.com/trials/effect-of-aged-garlic-extract-age-on-improving-coronary-atherosclerosis-in-people-with-type-2-diabetes-mellitus-4883 https://curecurrent.com/trials/renal-effects-of-three-iodinated-contrast-media-cm-in-patients-at-risk-undergoing-coronary-angiography-4884 https://curecurrent.com/trials/regulation-of-postprandial-nitric-oxide-bioavailability-and-vascular-function-by-dairy-fat-4885 https://curecurrent.com/trials/the-vbloct2d-study-4886 https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-mellitus-4887 https://curecurrent.com/trials/yoga-as-a-complementary-therapy-for-adults-with-type-2-diabetes-4888 https://curecurrent.com/trials/mitigation-of-type-2-diabetes-by-partial-ileal-bypass-4889 https://curecurrent.com/trials/efficacy-study-of-diabetes-group-visits-4890 https://curecurrent.com/trials/check-it-2-0-positive-psychology-intervention-for-adolescents-with-type-1-diabetes-4891 https://curecurrent.com/trials/health-literacy-intervention-for-african-americans-with-diabetes-4892 https://curecurrent.com/trials/gastrointestinal-sensorimotor-dysfunctions-in-diabetes-mellitus-4893 https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-mellitus-during-meal-challeng-4894 https://curecurrent.com/trials/anti-il-1-treatment-in-children-diabetic-keto-acidosis-dka-at-diagnosis-of-type-1-diabetes-4895 https://curecurrent.com/trials/group-education-curriculum-for-older-teens-with-type-1-diabetes-4896 https://curecurrent.com/trials/hybrid-closed-loop-pivotal-trial-in-type-1-diabetes-4897 https://curecurrent.com/trials/type-1-diabetes-data-acquisition-and-transfer-adherence-study-4898 https://curecurrent.com/trials/effect-of-hypoglycemia-on-sleep-4899 https://curecurrent.com/trials/mhealth-titration-and-management-4900 https://curecurrent.com/trials/pilam-go4health-weight-loss-program-to-prevent-heart-disease-4901 https://curecurrent.com/trials/care-guides-in-the-primary-care-office-phase-ii-4902 https://curecurrent.com/trials/targeting-inflammation-using-salsalate-in-type-2-diabetes-tinsal-t2d-4903 https://curecurrent.com/trials/children-with-diabetes-at-risk-for-heart-disease-4904 https://curecurrent.com/trials/fiber-mix-and-glycemic-response-4905 https://curecurrent.com/trials/cardiovascular-and-renal-microvascular-outcome-study-with-linagliptin-in-patients-with-type-2-diabetes-mellitus-carmelin-4906 https://curecurrent.com/trials/a-pilot-study-of-biomarkers-of-stress-in-youth-who-use-teens-connect-4907 https://curecurrent.com/trials/multiple-ascending-dose-study-of-mk-5160-in-participants-with-type-1-and-type-2-diabetes-mellitus-mk-5160-002-4908 https://curecurrent.com/trials/a-single-center-study-to-evaluate-the-efficacy-and-safety-of-etc-1002-in-subjects-with-type-2-diabetes-4909 https://curecurrent.com/trials/insulin-lispro-6-days-versus-insulin-aspart-6-days-in-pump-use-4910 https://curecurrent.com/trials/diabetes-and-gastric-by-pass-4911 https://curecurrent.com/trials/promoting-the-universal-medication-schedule-via-mobile-and-ehr-technologies-4912 https://curecurrent.com/trials/reducing-distress-and-improving-glycemic-control-in-adults-with-type-1-diabetes-4913 https://curecurrent.com/trials/the-statin-choice-decision-aid-for-type-2-diabetes-patients-4914 https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-glwl-01-4915 https://curecurrent.com/trials/a-euglycemic-insulin-clamp-study-in-type-1-diabetic-patients-with-oral-insulin-oramed-4916 https://curecurrent.com/trials/evaluation-of-soy-protein-russian-tarragon-artemisia-dracunculus-l-4917 https://curecurrent.com/trials/a-clinical-trial-to-prevent-new-onset-diabetes-after-transplantation-4918 https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-versus-placebo-as-add-on-to-existing-diabetes-medication-in-subjects-with-type-2-diab-4919 https://curecurrent.com/trials/hawaii-patient-reward-and-incentives-to-support-empowerment-4920 https://curecurrent.com/trials/lipid-biomarkers-for-diabetic-heart-disease-4921 https://curecurrent.com/trials/pharmacist-impact-on-pneumococcal-polysaccharide-vaccination-rates-in-patients-with-diabetes-in-a-supermarket-pharmacy-c-4922 https://curecurrent.com/trials/moderate-alcohol-and-cardiovascular-health-trial-4923 https://curecurrent.com/trials/a-phase-1-single-and-multiple-dose-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-me-4924 https://curecurrent.com/trials/a-digital-health-tool-for-insulin-titration-dhit-individuals-with-type-2-diabetes-a-prospective-outcomes-study-with-a-re-4925 https://curecurrent.com/trials/hyperbaric-oxygen-therapy-as-adjunctive-therapy-to-scaling-and-root-planing-in-the-management-of-periodontitis-in-patien-4926 https://curecurrent.com/trials/check-it-positive-psychology-intervention-to-improve-adherence-in-adolescents-with-t1d-4927 https://curecurrent.com/trials/preprandial-ghrelin-effect-4928 https://curecurrent.com/trials/a-phase-2-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-pf-00489791-in-patients-with-type-2-diabetes-a-4929 https://curecurrent.com/trials/an-educational-intervention-for-type-2-diabetes-patients-4930 https://curecurrent.com/trials/a-study-of-ly2605541-versus-insulin-glargine-on-blood-sugar-4931 https://curecurrent.com/trials/intraluminal-imaging-of-duodenal-layer-morphometry-in-patients-with-and-without-type-2-diabetes-4932 https://curecurrent.com/trials/oklahoma-native-american-women-s-osteoporosis-screening-study-4933 https://curecurrent.com/trials/a-study-to-evaluate-itca-650-for-the-treatment-of-type-2-diabetes-in-patients-with-high-baseline-hba1c-4934 https://curecurrent.com/trials/comparison-of-efficacy-safety-and-tolerability-of-itca-650-to-empagliflozin-and-glimepiride-as-add-on-metformin-4935 https://curecurrent.com/trials/providing-preventive-periodontal-treatment-to-hospitalized-patients-with-diabetes-4936 https://curecurrent.com/trials/effect-of-albiglutide-when-added-to-standard-blood-glucose-lowering-therapies-on-major-cardiovascular-events-in-subjects-4937 https://curecurrent.com/trials/pilot-study-of-between-visit-interaction-to-improve-glycemic-control-in-pregnancy-with-pre-existing-diabetes-4938 https://curecurrent.com/trials/post-approval-study-of-the-ts-feature-with-the-530g-pump-system-supplemented-with-commercial-patient-data-4939 https://curecurrent.com/trials/dapagliflozin-evaluation-in-patients-with-inadequately-controlled-type-1-diabetes-4940 https://curecurrent.com/trials/photobiomodulation-ketogenic-diet-for-treatment-of-mid-periphery-retinal-disorders-for-alzheimer-s-disease-prevention-4941 https://curecurrent.com/trials/connectedhearthealth-heart-failure-readmission-intervention-4942 https://curecurrent.com/trials/adipose-tissue-function-after-pancreas-transplantation-4943 https://curecurrent.com/trials/facilitating-improvements-in-kidney-health-using-a-smartphone-app-counseling-program-in-patients-with-diabetes-4944 https://curecurrent.com/trials/a-study-of-how-insulin-peglispro-ly2605541-and-insulin-glargine-affect-the-breakdown-of-fat-and-sugar-in-type-1-diabetic-4945 https://curecurrent.com/trials/improving-diabetes-control-through-peer-counseling-and-incentives-4946 https://curecurrent.com/trials/overnight-closed-loop-study-in-u-s-4947 https://curecurrent.com/trials/the-effects-of-passive-vibration-in-patients-with-diabetic-peripheral-neuropathy-4948 https://curecurrent.com/trials/parents-of-young-adults-with-type-1-diabetes-an-exploratory-study-4949 https://curecurrent.com/trials/ache-inhibitor-and-insulin-4950 https://curecurrent.com/trials/multi-center-study-comparing-efficacy-and-safety-of-frequently-modified-insulin-therapy-4951 https://curecurrent.com/trials/process-versus-outcomes-incentives-for-lipid-management-4952 https://curecurrent.com/trials/safety-efficacy-study-of-subcutaneously-injected-prandial-insulins-compared-to-insulin-lispro-alone-in-participants-with-4953 https://curecurrent.com/trials/a-randomized-controlled-trial-evaluating-one-drop-premium-with-afrezza-vs-one-drop-premium-alone-4954 https://curecurrent.com/trials/the-virtual-visit-for-women-with-gestational-diabetes-4955 https://curecurrent.com/trials/randomized-double-blind-2-way-crossover-study-of-csii-with-versus-without-pretreatment-with-human-hyaluronidase-4956 https://curecurrent.com/trials/role-of-exenatide-in-type-1-diabetes-4957 https://curecurrent.com/trials/pharmacokinetic-pk-pharmacodynamic-pd-and-safety-study-of-subcutaneously-administered-humalog-with-and-without-recombina-4958 https://curecurrent.com/trials/phase-ii-pharmacokinetics-study-of-humalog-and-humulin-r-with-and-without-rhuph20-in-type-1-diabetes-mellitus-4959 https://curecurrent.com/trials/study-to-evaluate-bacterial-activity-that-drives-the-progression-of-clinical-infection-4960 https://curecurrent.com/trials/12-week-study-of-ds-8500a-in-subjects-with-type-2-diabetes-mellitus-on-metformin-4961 https://curecurrent.com/trials/effect-of-melatonin-on-cardiometabolic-risk-full-4962 https://curecurrent.com/trials/nushield-affinity-for-the-treatment-of-neuropathic-diabetic-foot-ulcers-4963 https://curecurrent.com/trials/study-of-fibrogen-fg-3019-in-subjects-with-type-2-diabetes-mellitus-and-kidney-disease-on-acei-and-or-arb-therapy-4964 https://curecurrent.com/trials/collaborative-care-for-depression-and-diabetic-retinopathy-in-african-americans-4965 https://curecurrent.com/trials/study-of-dopamine-versus-vasopressin-for-treatment-of-low-blood-pressure-in-low-birth-weight-infants-4966 https://curecurrent.com/trials/advancing-diabetes-management-in-adolescents-using-health-information-technology-4967 https://curecurrent.com/trials/linagliptin-inpatient-trial-4968 https://curecurrent.com/trials/dynamic-study-diabetes-nurse-case-management-and-motivational-interviewing-for-change-4969 https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-mellitus-t1d-4970 https://curecurrent.com/trials/the-use-of-alpha-lipoic-acid-for-the-treatment-and-prevention-of-diabetic-retinopathy-4971 https://curecurrent.com/trials/biomarkers-in-exhaled-breath-of-glucose-fluctuation-in-type-1-diabetes-4972 https://curecurrent.com/trials/analysis-for-nsaid-vs-corticosteroid-shoulder-injection-in-diabetic-patients-4973 https://curecurrent.com/trials/effect-of-saxagliptin-on-epcs-as-a-cellular-biomarker-for-evaluating-endothelial-dysfunction-in-early-t2dm-patients-4974 https://curecurrent.com/trials/chronic-cardiovascular-risk-outpatient-management-in-south-asians-using-digital-health-technology-4975 https://curecurrent.com/trials/the-goodnews-lifestyle-enhancement-program-4976 https://curecurrent.com/trials/dose-safety-hybrid-closed-loop-and-fully-automated-closed-loop-artificial-pancreas-device-in-crc-4977 https://curecurrent.com/trials/the-effects-of-liraglutide-on-sudomotor-function-and-inflammation-in-type-2-diabetes-4978 https://curecurrent.com/trials/connected-catheter-c2p-study-for-bladder-management-4979 https://curecurrent.com/trials/randomized-controlled-clinical-trial-of-cinnamon-to-lower-hemoglobin-a1c-4980 https://curecurrent.com/trials/pathobiology-of-remission-of-type-2-diabetes-4981 https://curecurrent.com/trials/simultaneous-risk-factor-control-using-telehealth-to-slow-progression-of-diabetic-kidney-disease-stop-dkd-4982 https://curecurrent.com/trials/chinese-diabetes-prevention-program-chinese-dpp-4983 https://curecurrent.com/trials/men-together-making-a-difference-health-promotion-for-black-men-4984 https://curecurrent.com/trials/continuous-glucose-monitoring-in-type-2-diabetes-mellitus-4985 https://curecurrent.com/trials/lifestyle-intervention-program-for-women-with-gestational-diabetes-or-gestational-impaired-glucose-tolerance-4986 https://curecurrent.com/trials/community-based-participatory-research-to-improve-health-and-quality-of-life-of-latino-youth-every-little-step-counts-4987 https://curecurrent.com/trials/psychosocial-functioning-in-young-adults-with-type-1-diabetes-4988 https://curecurrent.com/trials/a-study-of-continuous-subcutaneous-insulin-infusion-csii-pump-function-in-subjects-with-type-1-diabetes-with-recombinant-4989 https://curecurrent.com/trials/tu-salud-your-health-randomized-control-study-in-patients-with-diabetes-using-a-mobile-app-4990 https://curecurrent.com/trials/vasopressin-plasma-concentrations-in-patients-receiving-exogenous-vasopressin-infusion-for-septic-shock-4991 https://curecurrent.com/trials/a-comparative-clinical-trial-of-the-tensortip-a-novel-non-invasive-device-for-measurement-blood-parameters-4992 https://curecurrent.com/trials/annular-array-ultrasound-in-ophthalmology-4993 https://curecurrent.com/trials/spinal-cord-stimulation-for-diabetic-polyneuropathy-4994 https://curecurrent.com/trials/efficacy-and-safety-of-fiasp-compared-to-insulin-aspart-in-combination-with-insulin-glargine-and-metformin-in-adults-wit-4995 https://curecurrent.com/trials/freestyle-libre-glucose-monitoring-system-in-pediatric-populations-4996 https://curecurrent.com/trials/a-study-of-ly3025876-in-participants-with-diabetes-4997 https://curecurrent.com/trials/treatment-of-diabetes-after-gastric-bypass-with-sitagliptin-4998 https://curecurrent.com/trials/negative-pressure-wound-therapy-as-a-drug-delivery-system-adanpwt-4999 https://curecurrent.com/trials/a-study-to-evaluate-pharmacokinetics-safety-and-efficacy-of-albiglutide-in-pediatric-subjects-with-type-2-diabetes-melli-5000 https://curecurrent.com/trials/early-screening-and-treatment-of-women-with-prediabetes-in-pregnancy-5001 https://curecurrent.com/trials/aggressive-versus-conservative-blood-glucose-control-in-hospitalized-type-2-diabetic-patients-using-detemir-and-aspart-i-5002 https://curecurrent.com/trials/the-impact-of-low-fat-and-full-fat-dairy-consumption-on-glucose-homeostasis-dairy-study-5003 https://curecurrent.com/trials/tedizolid-tissue-penetration-in-diabetic-patients-with-wound-infections-and-healthy-volunteers-via-in-vivo-microdialysis-5004 https://curecurrent.com/trials/tissue-penetration-of-ceftolozane-tazobactam-in-diabetic-patients-with-lower-limb-infections-5005 https://curecurrent.com/trials/changes-in-adiposity-metabolic-measures-from-atypicals-to-aripiprazole-5006 https://curecurrent.com/trials/coordinating-and-data-management-center-for-the-consortium-for-the-study-of-chronic-pancreatitis-diabetes-and-pancreatic-5007 https://curecurrent.com/trials/obtaining-and-storing-standard-of-care-wound-biopsies-for-immediate-or-future-wound-related-scientific-study-5008 https://curecurrent.com/trials/determining-dietary-pattern-accompanying-egg-intake-using-remote-food-photography-method-5009 https://curecurrent.com/trials/safety-and-efficacy-of-evolocumab-in-combination-with-statin-therapy-in-adults-with-diabetes-and-hyperlipidemia-or-mixed-5010 https://curecurrent.com/trials/closed-loop-glucagon-administration-for-hypoglycemia-treatment-5011 https://curecurrent.com/trials/use-of-the-insulin-pump-in-cystic-fibrosis-patients-with-impaired-glucose-tolerance-or-cfrd-and-in-type-1-diabetes-patie-5012 https://curecurrent.com/trials/can-group-visits-improve-outcomes-of-veterans-with-diabetes-5013 https://curecurrent.com/trials/mil-familias-santa-barbara-s-operational-pilot-to-understand-diabetes-in-the-latino-community-5014 https://curecurrent.com/trials/an-add-on-study-of-mlr-1023-in-adults-with-uncontrolled-type-2-diabetes-on-metformin-therapy-5015 https://curecurrent.com/trials/free-fatty-acids-induced-hypertension-in-obese-subjects-aim-2-5016 https://curecurrent.com/trials/phase-iii-study-to-evaluate-safety-and-efficacy-of-added-exenatide-versus-placebo-to-titrated-basal-insulin-glargine-in-5017 https://curecurrent.com/trials/efficacy-of-pramlintide-on-prevention-of-weight-gain-early-onset-of-type-1-diabetes-5018 https://curecurrent.com/trials/a-study-on-the-effects-of-ly2409021-on-the-electrical-impulses-of-the-heart-5019 https://curecurrent.com/trials/intrapartum-glucose-management-among-women-with-gestational-diabetes-mellitus-5020 https://curecurrent.com/trials/empagliflozin-as-adjunctive-to-insulin-therapy-over-52-weeks-in-patients-with-type-1-diabetes-mellitus-ease-2-5021 https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-safety-of-insulin-degludec-liraglutide-versus-insulin-glargine-in-subjects-with-type-5022 https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-safety-of-insulin-degludec-liraglutide-and-insulin-degludec-in-subjects-with-type-2-d-5023 https://curecurrent.com/trials/the-efficacy-of-insulin-degludec-liraglutide-in-controlling-glycaemia-in-adults-with-type-2-diabetes-inadequately-contro-5024 https://curecurrent.com/trials/a-trial-comparing-the-safety-and-efficacy-of-insulin-degludec-and-insulin-glargine-both-with-insulin-aspart-as-mealtime-5025 https://curecurrent.com/trials/phase-3-28-week-study-with-24-week-and-52-week-extension-phases-to-evaluate-efficacy-and-safety-of-exenatide-once-weekly-5026 https://curecurrent.com/trials/evaluation-of-the-dexcom-g6-continuous-glucose-monitoring-system-with-a-non-interferent-sensor-5027 https://curecurrent.com/trials/effectiveness-and-safety-of-the-dexcom-g6-continuous-glucose-monitoring-system-5028 https://curecurrent.com/trials/study-to-assess-the-safety-pharmacokinetics-and-pharmacodynamics-of-ds-1150b-in-healthy-subjects-and-subjects-with-type-5029 https://curecurrent.com/trials/health-coach-program-to-improve-chronic-disease-outcomes-following-an-emergency-department-visit-5030 https://curecurrent.com/trials/a-subjective-observational-study-of-patients-using-medicated-footbath-footwash-treatment-in-podiatry-care-5031 https://curecurrent.com/trials/web-based-intervention-designed-to-educate-and-improve-adherence-through-learning-to-use-continuous-glucose-monitoring-5032 https://curecurrent.com/trials/the-impact-of-mobile-technology-on-clinical-outcomes-in-children-and-adolescents-with-type-1-diabetes-5033 https://curecurrent.com/trials/side-effects-of-newer-antipsychotics-in-older-adults-5034 https://curecurrent.com/trials/ivacaftor-kalydeco-and-insulin-in-cystic-fibrosis-cf-5035 https://curecurrent.com/trials/rhubarb-and-angiotensin-converting-enzyme-inhibitor-5036 https://curecurrent.com/trials/controlling-hypertension-in-diabetes-feasibility-study-5037 https://curecurrent.com/trials/a-low-carbohydrate-diabetes-prevention-program-5038 https://curecurrent.com/trials/a-study-of-the-effects-of-canagliflozin-jnj-28431754-on-renal-endpoints-in-adult-participants-with-type-2-diabetes-melli-5039 https://curecurrent.com/trials/a-study-of-ly3209590-in-participants-with-type-2-diabetes-5040 https://curecurrent.com/trials/a-24-week-open-label-phase-3b-trial-with-a-28-week-extension-to-evaluate-the-efficacy-and-safety-of-saxagliptin-co-admin-5041 https://curecurrent.com/trials/digital-ankle-brachial-index-abi-as-a-screening-tool-in-detecting-peripheral-arterial-disease-5042 https://curecurrent.com/trials/screening-of-subjects-with-type-i-diabetes-to-determine-eligibility-for-islet-transplantation-5043 https://curecurrent.com/trials/glucose-response-of-g-pen-glucagon-injection-in-pediatric-t1d-patients-5044 https://curecurrent.com/trials/genetics-and-markers-of-degenerative-and-inflammatory-eye-diseases-5045 https://curecurrent.com/trials/canvas-canagliflozin-cardiovascular-assessment-study-5046 https://curecurrent.com/trials/dipeptidyl-peptidase-4-inhibitor-sitagliptin-therapy-in-the-inpatients-with-type-2-diabetes-5047 https://curecurrent.com/trials/evaluation-of-effect-of-doxycycline-verses-placebo-on-retinal-function-and-diabetic-retinopathy-5048 https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-5049 https://curecurrent.com/trials/utility-of-hemoglobin-a1c-for-the-diagnosis-of-gestational-diabetes-5050 https://curecurrent.com/trials/metformin-versus-insulin-in-pregnant-women-with-type-2-diabetes-5051 https://curecurrent.com/trials/metformin-postpartum-for-gdm-rct-for-reduced-weight-retention-5052 https://curecurrent.com/trials/the-set-point-study-evaluating-effects-of-changing-glucose-target-on-bionic-pancreas-performance-5053 https://curecurrent.com/trials/demonstrate-the-effects-of-pramlintide-on-weight-reduction-in-schizophrenia-5054 https://curecurrent.com/trials/a-study-of-ly2608204-in-patients-with-type-2-diabetes-5055 https://curecurrent.com/trials/a-multi-center-trial-to-evaluate-the-safety-and-efficacy-of-pegaptanib-sodium-macugen-injected-into-the-eye-every-6-week-5056 https://curecurrent.com/trials/effect-of-pharmacists-treating-diabetes-in-a-fqhc-5057 https://curecurrent.com/trials/a-study-to-estimate-the-effect-of-repeated-dosing-of-pf-05175157-on-the-pharmacokinetics-of-a-single-dose-of-simvastatin-5058 https://curecurrent.com/trials/diabetes-engagement-and-activation-platform-5059 https://curecurrent.com/trials/the-role-of-non-alcoholic-fatty-liver-disease-in-gestational-diabetes-5060 https://curecurrent.com/trials/home-exercise-to-enhance-mobility-for-older-diabetics-5061 https://curecurrent.com/trials/efficacy-of-amlexanox-vs-placebo-in-type-2-diabetic-patients-5062 https://curecurrent.com/trials/consistent-1-metabolic-and-safety-outcomes-of-hylenex-recombinant-hyaluronidase-human-injection-preadministered-at-csii-5063 https://curecurrent.com/trials/effects-of-aromatase-inhibition-versus-testosterone-in-older-men-with-low-testosterone-randomized-controlled-trial-5064 https://curecurrent.com/trials/harnessing-mhealth-and-social-support-to-improve-diabetes-related-health-behavior-for-inner-city-patients-5065 https://curecurrent.com/trials/study-of-the-safety-and-tolerability-of-switching-to-itca-650-in-patients-with-type-2-diabetes-receiving-liraglutide-5066 https://curecurrent.com/trials/aldosterone-and-the-metabolic-syndrome-5067 https://curecurrent.com/trials/empagliflozin-as-adjunctive-to-insulin-therapy-over-26-weeks-in-patients-with-t1dm-ease-3-5068 https://curecurrent.com/trials/modulation-of-stat3-signaling-with-siltuximab-in-type-1-diabetes-5069 https://curecurrent.com/trials/retrospective-evaluation-of-athens-complete-health-improvement-program-chip-database-5070 https://curecurrent.com/trials/effect-of-a-fixed-pramlintide-insulin-dose-ratio-on-postprandial-glucose-in-type-1-diabetes-mellitus-5071 https://curecurrent.com/trials/evaluation-of-doxycycline-verses-placebo-for-the-treatment-of-severe-nonproliferative-or-mild-or-moderate-proliferative-5072 https://curecurrent.com/trials/provider-initiated-regular-remote-interventions-for-optimal-type-2-diabetes-care-5073 https://curecurrent.com/trials/a-study-to-compare-the-effects-of-insulin-peglispro-and-glargine-on-insulin-sensitivity-and-meal-time-insulin-requiremen-5074 https://curecurrent.com/trials/satisfaction-of-treatment-among-elderly-patients-with-insulin-therapy-5076 https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-dapagliflozin-on-blood-glucose-level-and-renal-safety-in-patients-with-type-2-diabetes-5077 https://curecurrent.com/trials/safety-and-efficacy-of-g-pen-compared-to-lilly-glucagon-for-hypoglycemia-rescue-in-adult-type-1-diabetics-5078 https://curecurrent.com/trials/trial-between-a-computer-guided-insulin-infusion-protocol-versus-a-standard-insulin-infusion-algorithm-in-medical-icu-5079 https://curecurrent.com/trials/pilot-study-3-of-outpatient-control-to-range-safety-and-efficacy-with-day-and-night-in-home-use-5080 https://curecurrent.com/trials/women-s-lifestyle-balance-study-5081 https://curecurrent.com/trials/evaluation-of-a-prototype-diabetes-management-system-applied-to-insulin-initiation-and-titration-5082 https://curecurrent.com/trials/resveratrol-and-the-metabolic-syndrome-5083 https://curecurrent.com/trials/weight-loss-using-a-feedback-device-in-obese-people-with-the-metabolic-syndrome-5084 https://curecurrent.com/trials/direct-antibiotic-delivery-of-cefazolin-into-soft-tissue-infections-using-subcutaneous-injection-and-ultrasonic-dispersi-5085 https://curecurrent.com/trials/mhealth-intervention-for-older-adults-5086 https://curecurrent.com/trials/n-acetylcysteine-and-milk-thistle-for-treatment-of-diabetic-nephropathy-5087 https://curecurrent.com/trials/comparing-self-monitored-blood-glucose-smbg-to-continuous-glucose-monitoring-cgm-in-type-2-diabetes-5088 https://curecurrent.com/trials/guided-imagery-lifestyle-intervention-to-promote-health-and-prevent-diabetes-in-youth-5089 https://curecurrent.com/trials/miami-healthy-heart-initiative-a-behavioral-study-on-cardiovascular-risk-factors-5090 https://curecurrent.com/trials/study-to-evaluate-if-the-drug-vasopressin-protects-the-kidneys-for-patients-undergoing-liver-transplant-5091 https://curecurrent.com/trials/maptrek-to-increase-activity-among-patients-at-risk-for-type-2-diabetes-5092 https://curecurrent.com/trials/the-create-wellness-study-5093 https://curecurrent.com/trials/a-phase-1-single-multiple-dose-study-of-pf-06293620-to-assess-safety-tolerability-and-pharmacokinetics-in-subjects-with-5094 https://curecurrent.com/trials/motion-perception-in-individuals-with-type-2-diabetes-5095 https://curecurrent.com/trials/novel-therapies-for-metabolic-complications-of-lipodystrophies-5096 https://curecurrent.com/trials/impact-of-vitamin-d-on-diabetic-kidney-disease-in-african-americans-5097 https://curecurrent.com/trials/pathobiology-and-reversibility-of-prediabetes-in-a-biracial-cohort-5098 https://curecurrent.com/trials/mechanism-underlying-beta-cell-failure-in-obese-african-americans-with-history-of-hyperglycemic-crises-5099 https://curecurrent.com/trials/continuous-glucose-monitoring-to-assess-glycemia-in-chronic-kidney-disease-changing-glucose-management-5100 https://curecurrent.com/trials/coalition-for-a-healthier-community-utah-women-and-girls-phase-ii-uwag-ii-5101 https://curecurrent.com/trials/basal-bolus-versus-basal-insulin-in-type-2-diabetes-mellitus-t2dm-5102 https://curecurrent.com/trials/treating-prediabetes-in-the-first-trimester-5103 https://curecurrent.com/trials/getting-in-balance-a-workplace-diabetes-prevention-intervention-trial-5104 https://curecurrent.com/trials/a-multi-center-randomized-double-blind-phase-iii-trial-to-evaluate-the-safety-and-efficacy-of-saxagliptin-co-administere-5105 https://curecurrent.com/trials/efficacy-safety-trial-of-intravitreal-injections-combined-with-prp-for-csme-secondary-to-diabetes-mellitus-dave-5106 https://curecurrent.com/trials/efficacy-and-safety-of-switching-from-sitagliptin-to-liraglutide-in-subjects-with-type-2-diabetes-not-achieving-adequate-5107 https://curecurrent.com/trials/safety-and-efficacy-of-exubera-compared-with-subcutaneous-human-insulin-therapy-in-children-and-adolescents-5108 https://curecurrent.com/trials/fit-and-trim-for-diabetes-prevention-5109 https://curecurrent.com/trials/cep249-pediatric-accuracy-study-5110 https://curecurrent.com/trials/basal-insulin-in-the-management-of-patients-with-diabetic-ketoacidosis-dka-5111 https://curecurrent.com/trials/free-fatty-acids-and-vascular-function-in-subjects-with-diabetes-5112 https://curecurrent.com/trials/trial-of-dehydrated-human-amnion-chorion-membrane-dhacm-in-the-management-of-diabetic-foot-ulcers-5113 https://curecurrent.com/trials/reducing-risks-and-improving-glucose-control-during-extended-exercise-in-youth-with-t1dm-the-ap-ski-camp-5114 https://curecurrent.com/trials/multidisciplinary-team-approach-working-together-to-improve-glycemic-control-in-hispanic-adults-diabetes-5115 https://curecurrent.com/trials/periodontal-treatment-response-in-type-ii-diabetic-patients-5116 https://curecurrent.com/trials/efficacy-and-safety-of-toujeo-versus-tresiba-in-insulin-naive-patients-with-type-2-diabetes-mellitus-inadequately-contro-5117 https://curecurrent.com/trials/four-way-crossover-closed-loop-with-exercise-detection-5118 https://curecurrent.com/trials/dapagliflozin-evaluation-in-patients-with-inadequately-controlled-type-1-diabetes-5119 https://curecurrent.com/trials/impact-of-exenatide-on-sleep-in-type-2-diabetes-5120 https://curecurrent.com/trials/prevalence-of-non-alcoholic-fatty-liver-disease-nafld-in-hispanics-with-diabetes-mellitus-type-2-t2dm-and-role-of-treatm-5121 https://curecurrent.com/trials/diabetic-retinopathy-in-hiv-subjects-treated-with-egrifta-5122 https://curecurrent.com/trials/threshold-suspend-in-pediatrics-at-home-5123 https://curecurrent.com/trials/neuropathic-investigation-and-anticholinergic-treatment-of-bladder-dysfunction-in-diabetes-and-stroke-patients-5124 https://curecurrent.com/trials/three-way-interaction-between-gabapentin-duloxetine-and-donepezil-in-patients-with-diabetic-neuropathy-5125 https://curecurrent.com/trials/use-of-continuous-glucose-sensors-by-adolescents-with-inadequate-diabetic-control-5126 https://curecurrent.com/trials/physical-and-cognitive-function-look-ahead-ancillary-study-5127 https://curecurrent.com/trials/a-trial-investigating-the-efficacy-and-safety-of-insulin-detemir-versus-insulin-nph-in-combination-with-metformin-and-di-5128 https://curecurrent.com/trials/study-of-efficacy-and-tolerability-of-various-bowel-preps-in-diabetic-patients-5129 https://curecurrent.com/trials/hypoglycemia-in-hospitalized-patients-5130 https://curecurrent.com/trials/study-of-alemtuzumab-versus-anti-thymocyte-globulin-to-help-prevent-rejection-in-kidney-and-pancreas-transplantation-5131 https://curecurrent.com/trials/impact-of-non-glucose-signals-on-glycemic-control-in-patients-with-type-1-diabetes-5132 https://curecurrent.com/trials/safety-and-feasibility-evaluation-of-the-aps-app-5133 https://curecurrent.com/trials/safety-of-inhaled-preprandial-human-insulin-in-subjects-with-diabetes-and-asthma-5134 https://curecurrent.com/trials/healthyme-online-weight-management-education-healthyme-at-home-5135 https://curecurrent.com/trials/effect-of-inhaled-insulin-aerx-idms-on-blood-glucose-control-in-type-2-diabetes-5136 https://curecurrent.com/trials/a-clinical-study-to-investigate-and-compare-the-impact-of-high-protein-pasta-lower-protein-pasta-and-white-rice-on-blood-5137 https://curecurrent.com/trials/evaluating-weight-loss-programs-for-obese-people-at-risk-for-heart-disease-the-power-study-5138 https://curecurrent.com/trials/effect-of-inhaled-pre-prandial-human-insulin-on-blood-glucose-control-in-type-2-diabetes-5139 https://curecurrent.com/trials/safety-and-efficacy-of-inhaled-insulin-in-type-1-diabetes-5140 https://curecurrent.com/trials/study-of-human-plasma-derived-alpha1-proteinase-inhibitor-in-subjects-with-new-onset-type-1-diabetes-mellitus-5141 https://curecurrent.com/trials/effects-of-roflumilast-on-insulin-and-blood-sugar-levels-in-prediabetic-overweight-and-obese-individuals-5142 https://curecurrent.com/trials/effects-of-fatty-acid-delivery-on-heart-metabolism-and-function-in-type-2-diabetes-t2dm-5143 https://curecurrent.com/trials/environmental-polymorphisms-registry-health-and-exposures-survey-5144 https://curecurrent.com/trials/pioglitazone-and-serum-asymmetric-dimethylarginine-adma-in-patients-with-diabetes-5145 https://curecurrent.com/trials/evaluation-of-evolocumab-amg-145-efficacy-in-diabetic-adults-with-hypercholesterolemia-mixed-dyslipidemia-5146 https://curecurrent.com/trials/treatment-of-type-2-diabetes-with-ketogenic-diet-5147 https://curecurrent.com/trials/safety-study-of-ge-145-320-mg-i-ml-injection-vs-iopamidol-370-mg-i-ml-in-elderly-subjects-undergoing-coronary-procedure-5148 https://curecurrent.com/trials/assessment-of-intranasal-glucagon-in-children-and-adolescents-with-type-1-diabetes-5149 https://curecurrent.com/trials/to-evaluate-if-wide-blood-sugar-fluctuations-lead-to-injury-of-heart-function-and-heart-nerves-5150 https://curecurrent.com/trials/effect-of-dpp4-inhibition-on-vasoconstriction-5151 https://curecurrent.com/trials/study-of-subjects-with-diabetic-foot-ulcer-dfu-5152 https://curecurrent.com/trials/heat-therapy-and-cardiometabolic-health-in-obese-women-5153 https://curecurrent.com/trials/the-effect-of-nutrient-intake-on-the-microbiome-weight-and-glucoregulation-ni-mwg-5154 https://curecurrent.com/trials/ada-linagliptin-in-long-term-care-5155 https://curecurrent.com/trials/liraglutide-versus-insulin-mono-therapy-in-the-closed-loop-setting-5156 https://curecurrent.com/trials/ketogenic-diet-treatment-of-obesity-with-co-morbid-type-2-diabetes-mellitus-and-or-obstructive-sleep-apnea-5157 https://curecurrent.com/trials/parents-and-children-together-preventing-diabetes-pact-pd-5158 https://curecurrent.com/trials/absorption-and-safety-with-sustained-use-of-relizorb-evaluation-assure-study-5159 https://curecurrent.com/trials/piedmont-aging-cognition-exercise-study-2-5160 https://curecurrent.com/trials/lifestyle-intervention-for-treatment-of-diabetes-5161 https://curecurrent.com/trials/insulin-dosing-practices-in-persons-with-diabetes-on-multiple-daily-injections-5162 https://curecurrent.com/trials/the-effect-of-exercise-on-hepatic-glucose-metabolism-5163 https://curecurrent.com/trials/effect-of-bkr-013-on-average-daily-glucose-levels-5164 https://curecurrent.com/trials/macronutrient-effects-on-alzheimer-s-disease-meal-2-5165 https://curecurrent.com/trials/healthy-lifestyles-for-mentally-ill-people-who-have-experienced-weight-gain-from-their-antipsychotic-medications-2-5166 https://curecurrent.com/trials/a-trial-comparing-continuous-glucose-monitoring-with-and-without-routine-blood-glucose-monitoring-in-adults-with-type-1-5167 https://curecurrent.com/trials/closed-loop-insulin-delivery-in-children-less-than-7-years-of-age-5168 https://curecurrent.com/trials/exenatide-study-of-cardiovascular-event-lowering-trial-exscel-a-trial-to-evaluate-cardiovascular-outcomes-after-treatmen-5169 https://curecurrent.com/trials/use-of-track-health-function-of-the-myhealthevet-personal-health-record-5170 https://curecurrent.com/trials/randomized-trial-comparing-sitagliptin-to-placebo-in-closed-loop-5171 https://curecurrent.com/trials/a-trial-of-incentives-and-peer-mentors-to-improve-diabetic-outcomes-5172 https://curecurrent.com/trials/a-clinical-study-to-collect-calibration-performance-data-of-the-kbs-systems-1-0-non-invasive-glucose-monitoring-device-5173 https://curecurrent.com/trials/user-study-for-enhanced-meter-feature-5174 https://curecurrent.com/trials/pre-post-evaluation-of-temperature-steps-and-glucose-with-additional-time-spent-outdoors-in-an-urban-and-rural-setting-5175 https://curecurrent.com/trials/mechanisms-of-weight-loss-with-sglt2-inhibition-5176 https://curecurrent.com/trials/glycemic-effects-of-honey-5177 https://curecurrent.com/trials/a-study-to-assess-the-safety-of-pf-06342674-in-adults-with-type-1-diabetes-5178 https://curecurrent.com/trials/safety-study-to-examine-the-systemic-exposure-of-granexin-gel-after-topical-application-to-diabetic-foot-ulcers-5179 https://curecurrent.com/trials/use-of-santyl-in-diabetic-foot-ulcers-5180 https://curecurrent.com/trials/step-and-go-a-study-of-technology-based-exercise-promotion-5181 https://curecurrent.com/trials/study-of-hdv-insulin-versus-insulin-in-type-1-diabetes-subjects-isle-1-5182 https://curecurrent.com/trials/fatty-liver-study-in-patients-with-type-ii-diabetes-5183 https://curecurrent.com/trials/comparison-of-hepatic-directed-vesicle-hdv-insulin-lispro-versus-insulin-lispro-to-further-improve-glycemic-control-5184 https://curecurrent.com/trials/24-week-efficacy-and-safety-study-of-empagliflozin-bi-10773-in-hypertensive-black-african-american-patients-with-type-2-5185 https://curecurrent.com/trials/21-day-comparison-of-continuous-insulin-infusion-using-hdv-insulin-to-standard-insulin-in-type-1-diabetes-mellitus-5186 https://curecurrent.com/trials/immunogenicity-and-safety-study-of-glaxosmithkline-gsk-biologicals-engerix-b-in-adults-with-or-without-type-2-diabetes-m-5187 https://curecurrent.com/trials/assessment-of-eyeart-as-an-automated-diabetic-retinopathy-screening-tool-5188 https://curecurrent.com/trials/pilot-assessment-of-eyeart-as-an-automated-diabetic-retinopathy-screening-tool-5189 https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-in-pediatric-populations-5190 https://curecurrent.com/trials/a-study-of-multiple-doses-of-ly2922470-in-participants-with-diabetes-5191 https://curecurrent.com/trials/effectiveness-study-of-pramlintide-to-treat-post-transplant-diabetes-mellitus-5192 https://curecurrent.com/trials/evaluating-how-the-treatments-in-the-action-to-control-cardiovascular-risk-in-diabetes-accord-study-affect-diabetic-reti-5193 https://curecurrent.com/trials/feasibility-study-of-retinal-screening-using-the-retinavue-100-camera-in-outpatient-dialysis-centers-5194 https://curecurrent.com/trials/a-study-of-ly2409021-on-blood-pressure-and-pulse-rate-in-participants-with-type-2-diabetes-mellitus-5195 https://curecurrent.com/trials/efficacy-of-oral-antibiotic-therapy-compared-to-intravenous-antibiotic-therapy-for-osteomyelitis-5196 https://curecurrent.com/trials/detemir-role-in-type-1-diabetes-5197 https://curecurrent.com/trials/metformin-and-congenital-nephrogenic-diabetes-insipidus-5198 https://curecurrent.com/trials/a-follow-on-trial-to-assess-the-long-term-safety-and-efficacy-of-spm-927-in-painful-distal-diabetic-neuropathy-5199 https://curecurrent.com/trials/use-of-insulin-glargine-to-treat-diabetic-ketoacidosis-5200 https://curecurrent.com/trials/sglt2-inhibition-in-diabetes-and-heart-failure-5201 https://curecurrent.com/trials/sitagliptin-dose-determination-study-5202 https://curecurrent.com/trials/feasibility-evaluation-of-an-artificial-pancreas-with-glucose-prediction-trust-index-5203 https://curecurrent.com/trials/taking-on-diabetes-to-advance-you-today-5204 https://curecurrent.com/trials/a-study-of-single-and-multiple-doses-of-oral-insulin-or-placebo-in-subjects-with-type-2-diabetes-mellitus-5205 https://curecurrent.com/trials/feasibility-study-using-run-to-run-control-to-optimize-continuous-glucose-sensor-bias-5206 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-cyclo-z-in-patients-with-obese-type-2-diabetes-5207 https://curecurrent.com/trials/tracking-neurodegeneration-in-early-wolfram-syndrome-5208 https://curecurrent.com/trials/pharmacist-led-group-medical-visits-to-help-with-diabetes-management-5209 https://curecurrent.com/trials/t1dm-immunotherapy-using-cd4-cd127lo-cd25-polyclonal-tregs-5210 https://curecurrent.com/trials/retinavue-diabetic-screening-5211 https://curecurrent.com/trials/post-meal-insulin-dosing-with-adjuvant-pre-meal-pramlintide-in-children-with-type-1-diabetes-mellitus-5212 https://curecurrent.com/trials/oxytocin-and-arginine-vasopressin-in-pain-relief-5213 https://curecurrent.com/trials/effects-of-antidiabetic-medications-on-the-postprandial-state-in-prediabetes-5214 https://curecurrent.com/trials/hybrid-closed-loop-hotel-studies-with-medtronic-pid-controller-5215 https://curecurrent.com/trials/linagliptin-as-add-on-to-basal-insulin-in-the-elderly-5216 https://curecurrent.com/trials/screening-brief-intervention-and-referral-to-treatment-in-primary-care-5217 https://curecurrent.com/trials/efficacy-and-safety-of-exenatide-once-weekly-suspension-in-subjects-with-type-2-diabetes-5218 https://curecurrent.com/trials/a-study-in-patients-with-type-2-diabetes-mellitus-5219 https://curecurrent.com/trials/sleep-coping-and-executive-functioning-in-youth-with-type-1-diabetes-5220 https://curecurrent.com/trials/frequency-of-blood-glucose-monitoring-in-patients-with-gestational-diabetes-5221 https://curecurrent.com/trials/study-to-determine-if-different-prosthetic-sockets-effect-how-much-oxygen-is-in-the-tissue-of-lower-limb-amputees-while-5222 https://curecurrent.com/trials/a-proposed-study-of-atherosclerotic-plaques-in-leg-arteries-5223 https://curecurrent.com/trials/use-of-subtle-vibration-to-improve-walking-ability-by-lower-limb-amputees-5224 https://curecurrent.com/trials/balancing-treatment-outcomes-and-medication-burden-among-patients-with-symptomatic-diabetic-peripheral-neuropathy-5225 https://curecurrent.com/trials/powerup-for-health-a-diabetes-prevention-program-for-men-5226 https://curecurrent.com/trials/tissue-specific-metabolic-reprogramming-in-diabetic-complications-5227 https://curecurrent.com/trials/comfort-and-antimicrobial-efficacy-of-chlorhexidine-vs-betadine-for-intravitreal-injections-5228 https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-isis-gcgrrx-in-patients-with-type-2-diabetes-5229 https://curecurrent.com/trials/randomized-control-trial-of-fluid-therapy-for-pediatric-diabetic-ketoacidosis-5230 https://curecurrent.com/trials/prevention-of-cystic-fibrosis-diabetes-5231 https://curecurrent.com/trials/an-outpatient-study-of-automated-blood-glucose-control-with-an-insulin-only-bionic-pancreas-5232 https://curecurrent.com/trials/use-of-sitagliptin-for-stress-hyperglycemia-or-mild-diabetes-following-cardiac-surgery-5233 https://curecurrent.com/trials/study-of-adrenalectomy-versus-observation-for-subclinical-hypercortisolism-5234 https://curecurrent.com/trials/effect-of-bydureon-on-carotid-atherosclerosis-progression-in-type-2-diabetes-mellitus-5235 https://curecurrent.com/trials/intravitreal-alfibercept-for-center-involved-dme-previously-managed-with-intravitreal-ranibizumab-5236 https://curecurrent.com/trials/development-of-a-novel-anti-hyperglycemic-agent-5237 https://curecurrent.com/trials/a-research-trial-of-aralast-in-new-onset-diabetes-retain-5238 https://curecurrent.com/trials/function-of-implanted-glucose-sensor-2-5239 https://curecurrent.com/trials/insulet-artificial-pancreas-evaluating-meal-performance-and-moderate-exercise-ide2-5240 https://curecurrent.com/trials/osteomyelitis-procalcitonin-to-diagnose-and-monitor-osteomyelitis-5241 https://curecurrent.com/trials/a-study-for-patients-with-type-2-diabetes-5242 https://curecurrent.com/trials/incentives-cognitive-training-and-internet-therapy-for-teens-with-poorly-controlled-type-1-diabetes-5243 https://curecurrent.com/trials/evaluation-of-the-accuracy-of-an-implanted-glucose-sensor-5244 https://curecurrent.com/trials/evaluation-of-extended-infusion-set-wear-using-medtronic-extended-wear-sof-set-infusion-set-5245 https://curecurrent.com/trials/lifestyle-changes-through-exercise-and-nutrition-5246 https://curecurrent.com/trials/a-study-of-atrasentan-on-reducing-albuminuria-in-type-2-diabetic-nephropathy-treated-with-renin-angiotensin-system-inhib-5247 https://curecurrent.com/trials/reversal-of-hypoglycemia-unawareness-using-continuous-glucose-monitoring-5248 https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-saxagliptin-co-administered-with-dapagliflozin-in-combination-with-metformi-5249 https://curecurrent.com/trials/bright-1-bodies-weight-management-program-5250 https://curecurrent.com/trials/a-performance-evaluation-of-the-enlite-glucose-sensor-to-support-a-full-144-hours-6days-of-use-5251 https://curecurrent.com/trials/effect-of-endoplasmic-reticulum-stress-on-metabolic-function-5252 https://curecurrent.com/trials/the-role-of-cholinergic-signaling-for-mediating-the-effects-of-gip-and-or-xenin-25-on-insulin-secretion-5253 https://curecurrent.com/trials/serum-vasopressin-levels-and-severe-hemorrhagic-shock-5254 https://curecurrent.com/trials/effect-of-food-order-on-postprandial-glucose-excursions-in-pre-diabetes-5255 https://curecurrent.com/trials/study-to-compare-efficacy-of-the-minimed-paradigm-real-time-system-vs-mdi-in-subjects-naive-to-insulin-pump-therapy-5256 https://curecurrent.com/trials/exercise-activity-based-bolus-decisions-in-type-1-diabetes-5257 https://curecurrent.com/trials/study-of-ac-201-in-patients-with-type-2-diabetes-mellitus-5258 https://curecurrent.com/trials/dermagraft-r-for-the-treatment-of-patients-with-diabetic-foot-ulcers-5259 https://curecurrent.com/trials/pivotal-trial-of-dermagraft-r-to-treat-diabetic-foot-ulcers-5260 https://curecurrent.com/trials/accu-chek-connect-at-school-cats-pediatric-study-5261 https://curecurrent.com/trials/effect-of-gain-on-closed-loop-insulin-5262 https://curecurrent.com/trials/efficacy-and-safety-of-alirocumab-versus-placebo-on-top-of-maximally-tolerated-lipid-lowering-therapy-in-patients-with-h-5263 https://curecurrent.com/trials/effects-of-fish-oils-on-inflammation-and-insulin-resistance-5264 https://curecurrent.com/trials/ozurdex-for-diabetic-macular-edema-treated-with-pars-plana-vitrectomy-and-membrane-removal-opera-study-5265 https://curecurrent.com/trials/safety-and-efficacy-of-s-707106-in-subjects-with-type-2-diabetes-mellitus-and-inadequate-glycemic-control-with-metformin-5266 https://curecurrent.com/trials/effects-of-lean-pork-high-protein-breakfast-on-satiety-and-metabolic-health-in-pre-diabetes-5267 https://curecurrent.com/trials/addressing-diabetes-together-5268 https://curecurrent.com/trials/epithelial-sodium-channel-enac-as-a-novel-mechanism-for-hypertension-and-volume-expansion-in-type-2-diabetes-5269 https://curecurrent.com/trials/fat-metabolism-in-pregnancy-and-neonatal-heart-function-in-diabetes-5270 https://curecurrent.com/trials/implementing-diabetes-group-visits-in-community-health-centers-5271 https://curecurrent.com/trials/t-ir-study-to-understand-the-effects-of-testosterone-and-estrogen-on-the-body-s-response-to-the-hormone-insulin-5272 https://curecurrent.com/trials/social-determinants-of-health-in-diabetes-outcomes-5273 https://curecurrent.com/trials/the-effects-of-bethanechol-on-glucose-homeostasis-5274 https://curecurrent.com/trials/feasibility-of-delivering-a-complex-behavioral-intervention-for-young-adults-with-diabetes-via-telehealth-5275 https://curecurrent.com/trials/validation-of-insulin-protocol-for-glucocorticoid-induced-hyperglycemia-in-diabetic-oncology-patients-5276 https://curecurrent.com/trials/international-diabetes-closed-loop-idcl-trial-research-site-training-protocol-5277 https://curecurrent.com/trials/partnerships-to-improve-lifestyle-interventions-pili-ohana-dissemination-project-partners-in-care-5278 https://curecurrent.com/trials/the-diabetic-foot-ulcer-registry-5279 https://curecurrent.com/trials/quantitative-in-vivo-biomarkers-of-oxidative-stress-in-diabetes-5280 https://curecurrent.com/trials/study-of-the-effects-of-xenin-25-in-humans-with-and-without-type-2-diabetes-mellitus-5281 https://curecurrent.com/trials/a-study-to-compare-a-new-long-acting-insulin-ly2605541-and-human-insulin-nph-in-participants-with-type-2-diabetes-5282 https://curecurrent.com/trials/health-promoters-and-pharmacists-in-diabetes-team-management-5283 https://curecurrent.com/trials/vitamin-d-deficiency-insulin-resistance-and-fgf-23-5284 https://curecurrent.com/trials/efficacy-and-safety-of-alirocumab-versus-usual-care-on-top-of-maximally-tolerated-statin-therapy-in-patients-with-type-2-5285 https://curecurrent.com/trials/evaluating-the-feasibility-of-using-m-health-to-improve-serum-glucose-logs-5286 https://curecurrent.com/trials/cellular-and-tissue-based-therapy-registry-5287 https://curecurrent.com/trials/negative-pressure-wound-therapy-registry-5288 https://curecurrent.com/trials/dose-ranging-study-to-evaluate-the-glycemic-effects-safety-and-tolerability-of-metformin-delayed-release-in-subjects-wit-5289 https://curecurrent.com/trials/intervening-in-diabetes-with-healthy-eating-activity-and-linkages-to-healthcare-the-i-d-health-study-5290 https://curecurrent.com/trials/characteristics-of-patients-with-type-2-diabetes-mellitus-receiving-treatment-with-dapagliflozin-versus-sitagliptin-an-a-5291 https://curecurrent.com/trials/study-to-assess-safety-and-pharmacokinetics-of-double-blind-s-707106-alone-and-in-combination-with-open-label-metformin-5292 https://curecurrent.com/trials/improving-diabetes-outcomes-with-activity-nutrition-and-medication-5293 https://curecurrent.com/trials/study-to-compare-pharmacokinetics-pharmacodynamics-of-warfarin-esmolol-in-the-absence-presence-of-medi0382-5294 https://curecurrent.com/trials/maternal-adipose-tissue-and-placental-dysfunction-programs-the-fetus-for-type-2-diabetes-placenta-dm-5295 https://curecurrent.com/trials/a-study-for-participants-with-type-2-diabetes-mellitus-5296 https://curecurrent.com/trials/a-study-of-ly2409021-in-patients-with-type-2-diabetes-5297 https://curecurrent.com/trials/genetic-risk-and-health-coaching-for-type-2-diabetes-and-coronary-heart-disease-5298 https://curecurrent.com/trials/mad-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pb-119-to-subjects-with-t2dm-5299 https://curecurrent.com/trials/a-study-of-ly2605541-in-participants-with-type-2-diabetes-mellitus-5300 https://curecurrent.com/trials/a-study-of-ly2605541-in-participants-with-type-1-diabetes-mellitus-5301 https://curecurrent.com/trials/a-mobile-phone-based-program-for-adults-with-prediabetes-5302 https://curecurrent.com/trials/study-in-postmenopausal-women-with-type-2-diabetes-looking-at-approved-diabetes-drugs-and-how-they-affect-bone-health-5303 https://curecurrent.com/trials/role-of-pregnancy-related-hormones-in-lowering-the-insulin-requirement-in-pregnant-women-with-type-1-diabetes-5304 https://curecurrent.com/trials/comparator-trial-using-insulin-glulisine-vs-insulin-lispro-for-treatment-of-gestational-diabetes-5305 https://curecurrent.com/trials/a-study-in-participants-with-type-2-diabetes-mellitus-5306 https://curecurrent.com/trials/a-study-in-participants-with-type-i-diabetes-mellitus-5307 https://curecurrent.com/trials/a-study-in-participants-with-type-1-diabetes-mellitus-5308 https://curecurrent.com/trials/a-study-for-patients-with-type-1-diabetes-5309 https://curecurrent.com/trials/sequencing-t-cells-in-type-i-diabetes-mellitus-5310 https://curecurrent.com/trials/a-study-in-patients-with-type-2-diabetes-mellitus-5311 https://curecurrent.com/trials/use-of-exenatide-and-pramlintide-to-decrease-post-prandial-hyperglycemia-5312 https://curecurrent.com/trials/use-of-levemir-improves-metabolic-and-clinical-status-in-cystic-fibrosis-related-diabetes-cfrd-5313 https://curecurrent.com/trials/salivary-transcriptome-biomarkers-for-early-diabetes-detection-5314 https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-pk-and-pd-response-of-pe0139-injection-in-adult-subjects-with-t2dm-5315 https://curecurrent.com/trials/dose-escalation-study-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-remd-477-in-subjects-with-5316 https://curecurrent.com/trials/glucose-to-goal-a-model-to-support-diabetes-management-in-primary-care-5317 https://curecurrent.com/trials/diabetes-prp-and-oct-5318 https://curecurrent.com/trials/hemofiltration-in-burns-rescue-randomized-controlled-evaluation-of-hemofiltration-in-adult-burn-patients-with-septic-sho-5319 https://curecurrent.com/trials/pilot-study-of-oct-versus-fluorescein-angiography-in-dme-5320 https://curecurrent.com/trials/diabetes-self-management-support-live-5321 https://curecurrent.com/trials/pk-pd-study-with-g-pump-glucagon-infusion-in-t1dm-patients-5322 https://curecurrent.com/trials/cardia-brain-mri-substudy-5323 https://curecurrent.com/trials/a-study-evaluating-the-effect-of-albiglutide-on-gallbladder-emptying-in-healthy-subjects-5324 https://curecurrent.com/trials/longitudinal-study-in-perimenopausal-women-with-risk-factors-for-atherosclerosis-5325 https://curecurrent.com/trials/foundations-for-health-5326 https://curecurrent.com/trials/boosting-emotions-happiness-in-outpatients-living-with-diabetes-phase-i-5327 https://curecurrent.com/trials/a-study-of-the-function-of-hormones-present-in-taste-buds-5328 https://curecurrent.com/trials/safety-and-efficacy-study-of-mini-dose-glucagon-g-pen-mini-in-patients-with-type-1-diabetes-5329 https://curecurrent.com/trials/development-of-self-regulation-in-individuals-with-type-2-diabetes-5330 https://curecurrent.com/trials/fat-grafting-for-pedal-fat-pad-atrophy-in-diabetics-5331 https://curecurrent.com/trials/antihypertensive-medication-exposure-as-risk-for-impaired-glucose-tolerance-a-pear-sub-study-5332 https://curecurrent.com/trials/ghrelin-and-beta-cell-function-in-diabetes-5333 https://curecurrent.com/trials/a-26-week-trial-comparing-efficacy-and-safety-of-insulin-degludec-insulin-aspart-bid-and-insulin-degludec-od-plus-insuli-5334 https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-two-different-dose-adjustment-regimens-for-insulin-degludec-insulin-aspart-in-s-5335 https://curecurrent.com/trials/preferred-treatment-of-type-1-5-diabetes-5336 https://curecurrent.com/trials/a-clinical-trial-comparing-efficacy-and-safety-of-insulin-degludec-liraglutide-ideglira-versus-basal-bolus-therapy-in-su-5337 https://curecurrent.com/trials/subanalyses-of-elderly-type-2-diabetes-patients-or-type-2-diabetes-patients-with-renal-impairment-5338 https://curecurrent.com/trials/primary-care-community-partnerships-to-prevent-diabetes-5339 https://curecurrent.com/trials/personalized-smartphone-assisted-coaching-system-to-improve-glucose-homeostasis-in-adults-with-prediabetes-5340 https://curecurrent.com/trials/prospective-assessment-in-newborns-for-diabetes-autoimmunity-5341 https://curecurrent.com/trials/golo-open-label-pilot-1-5342 https://curecurrent.com/trials/effect-of-sulodexide-in-early-diabetic-nephropathy-5343 https://curecurrent.com/trials/insulin-detemir-compared-to-insulin-glargine-appetite-and-calories-consumed-in-type-1-diabetes-5344 https://curecurrent.com/trials/a-couples-based-approach-for-increasing-physical-activity-among-adults-with-type-2-diabetes-5345 https://curecurrent.com/trials/efficacy-and-safety-study-of-rosiglitazone-metformin-therapy-vs-rosiglitazone-and-metformin-in-type-2-diabetes-subjects-5346 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-an-investigational-diabetes-drug-in-poorly-controlled-type-ii-diabetics-5347 https://curecurrent.com/trials/a-new-oral-treatment-for-type-ii-diabetes-mellitus-5348 https://curecurrent.com/trials/ed-management-of-severe-hyperglycemia-a-clinical-trial-5349 https://curecurrent.com/trials/whole-grains-gastric-emptying-and-glycemic-response-5350 https://curecurrent.com/trials/improving-risk-factors-for-diabetes-complications-in-primary-care-5351 https://curecurrent.com/trials/comparison-of-time-restricted-feeding-versus-grazing-5352 https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-participants-with-type-1-diabetes-mellitus-t1dm-5353 https://curecurrent.com/trials/high-risk-obstetrical-patient-intervention-utilizing-the-contraceptive-choice-project-script-5354 https://curecurrent.com/trials/dermacell-in-subjects-with-chronic-wounds-of-the-lower-extremities-5355 https://curecurrent.com/trials/parental-management-of-young-children-s-diabetes-5356 https://curecurrent.com/trials/increased-gluconeogenesis-is-one-cause-of-cystic-fibrosis-related-diabetes-cfrd-5357 https://curecurrent.com/trials/a-complex-contraception-registry-5358 https://curecurrent.com/trials/home-testing-of-day-and-night-closed-loop-with-pump-suspend-feature-5359 https://curecurrent.com/trials/a-study-to-assess-the-bioequivalence-of-dapagliflozin-metformin-xr-fixed-dose-combination-tablets-in-healthy-subjects-5360 https://curecurrent.com/trials/brief-cbt-interventions-delivered-by-nurse-care-managers-to-improve-type-2-diabetes-outcomes-pilot-study-5361 https://curecurrent.com/trials/effect-of-sitagliptin-on-short-term-metabolic-dysregulation-of-oral-glucocorticoid-therapy-5362 https://curecurrent.com/trials/opt2mise-glucose-control-in-type-2-diabetes-mellitus-dm-with-insulin-pump-therapy-5363 https://curecurrent.com/trials/evaluate-the-efficacy-of-insulin-patients-with-type-1-diabetes-5364 https://curecurrent.com/trials/study-of-human-insulin-inhalation-powder-in-patients-with-type-1-diabetes-5365 https://curecurrent.com/trials/compare-two-dosing-algorithms-in-insulin-naive-patients-with-type-2-diabetes-mellitus-5366 https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-insulin-compared-to-glargine-in-patients-with-type-2-diabetes-5367 https://curecurrent.com/trials/mechanisms-of-diabetes-control-after-weight-loss-surgery-5368 https://curecurrent.com/trials/drugs-for-high-blood-pressure-and-high-cholesterol-in-american-indians-with-type-2-diabetes-5369 https://curecurrent.com/trials/testing-state-of-the-art-remote-glucose-monitoring-at-diabetes-camp-5370 https://curecurrent.com/trials/insulin-resistance-and-insulin-secretion-5371 https://curecurrent.com/trials/diabetes-prevention-program-5372 https://curecurrent.com/trials/the-diabetes-telecare-study-5373 https://curecurrent.com/trials/effects-of-resveratrol-on-endothelial-function-in-type-2-diabetes-mellitus-5374 https://curecurrent.com/trials/new-ways-to-help-patients-improve-their-diabetes-control-5375 https://curecurrent.com/trials/dose-dependent-effects-of-erythritol-on-endothelial-function-in-type-2-diabetes-mellitus-5376 https://curecurrent.com/trials/development-of-algorithms-for-a-hypoglycemic-prevention-alarm-closed-loop-study-5377 https://curecurrent.com/trials/dose-comparisons-of-leucine-metformin-combinations-on-blood-glucose-levels-in-type-2-diabetic-patients-5378 https://curecurrent.com/trials/using-a-motivational-interviewing-mi-informed-text-messaging-program-to-lower-blood-sugar-in-diabetic-patients-5379 https://curecurrent.com/trials/polyunsaturated-fatty-acids-pufa-in-diabetic-fatty-liver-5380 https://curecurrent.com/trials/a-pilot-clinical-trial-of-exendin-4-in-alzheimer-s-disease-5381 https://curecurrent.com/trials/uncovering-the-origins-of-diabetes-5382 https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-abbott-sensor-based-glucose-monitoring-systems-5383 https://curecurrent.com/trials/optimizing-behavioral-health-homes-for-adults-with-serious-mental-illness-5384 https://curecurrent.com/trials/closed-loop-system-with-pramlintide-versus-exenatide-5385 https://curecurrent.com/trials/video-games-for-obesity-and-diabetes-prevention-diab-nano-5386 https://curecurrent.com/trials/effects-of-dietary-supplement-tauroursodeoxycholic-acid-on-vascular-function-5387 https://curecurrent.com/trials/dual-action-of-liraglutide-and-insulin-degludec-in-type-2-diabetes-a-trial-comparing-the-efficacy-and-safety-of-insulin-5388 https://curecurrent.com/trials/study-comparing-versajet-with-conventional-surgical-procedures-in-the-removal-of-unhealthy-tissue-from-lower-limb-ulcers-5389 https://curecurrent.com/trials/the-study-of-inflammation-on-blood-glucose-levels-in-obese-people-5390 https://curecurrent.com/trials/vasopressin-administration-during-laparoscopic-myomectomy-a-randomized-controlled-trial-5391 https://curecurrent.com/trials/smart-technology-for-weight-loss-and-metabolic-health-5392 https://curecurrent.com/trials/bnp-pharmacodynamics-and-effects-on-metabolism-in-lean-and-obese-subjects-5393 https://curecurrent.com/trials/stories-for-change-digital-storytelling-as-a-tool-for-engagement-in-facilitated-discussion-for-diabetes-5394 https://curecurrent.com/trials/a-pilot-study-investigating-bioequivalence-between-a-single-dose-of-formulation-2-and-formulation-3-of-medi0382-5395 https://curecurrent.com/trials/safety-and-efficacy-of-incb013739-plus-metformin-compared-to-metformin-alone-on-glycemic-control-in-type-2-diabetics-5396 https://curecurrent.com/trials/improving-medication-safety-and-cvd-risk-factor-control-in-kidney-transplant-recipients-5397 https://curecurrent.com/trials/effects-of-branch-chain-amino-acids-on-glucose-tolerance-in-obese-pre-diabetic-subjects-5398 https://curecurrent.com/trials/pharmacologic-treatment-of-congenital-nephrogenic-diabetes-insipidus-5399 https://curecurrent.com/trials/single-dose-and-multiple-dose-safety-and-tolerability-study-of-pf-04856883-in-type-2-diabetic-adult-females-5400 https://curecurrent.com/trials/study-of-the-effectiveness-and-safety-of-sugardown-vs-placebo-in-type-2-diabetic-subjects-treated-with-metformin-5401 https://curecurrent.com/trials/comparing-google-with-a-focused-diabetes-search-engine-5402 https://curecurrent.com/trials/combinatorial-therapy-for-peristent-type-2-diabetes-after-gastric-banding-5403 https://curecurrent.com/trials/prandial-insulin-dosing-in-hospitalized-patients-5404 https://curecurrent.com/trials/controlling-hyperglycemia-among-minority-population-5405 https://curecurrent.com/trials/a-comparison-of-the-checkup-vision-assessment-system-to-standard-vision-assessment-tools-5406 https://curecurrent.com/trials/effects-of-mifepristone-on-biomarkers-of-metabolic-function-and-neuropsychological-performance-among-middle-aged-and-old-5407 https://curecurrent.com/trials/evaluating-the-influence-of-diabetes-stigma-on-medication-adherence-5408 https://curecurrent.com/trials/effectiveness-of-aurix-therapy-in-diabetic-foot-ulcers-5409 https://curecurrent.com/trials/sitagliptin-metformin-compared-to-metformin-monotherapy-and-placebo-in-women-with-a-recent-gdm-5410 https://curecurrent.com/trials/egg-intake-and-risk-of-type-2-diabetes-5411 https://curecurrent.com/trials/cocoa-polyphenols-and-postprandial-metabolism-in-type-2-diabetes-5412 https://curecurrent.com/trials/effect-of-liraglutide-on-body-weight-in-non-diabetic-obese-subjects-or-overweight-subjects-with-co-morbidities-scale-obe-5413 https://curecurrent.com/trials/comparison-of-sar342434-to-humalog-as-the-rapid-acting-insulin-in-adult-patients-with-type-1-diabetes-mellitus-also-usin-5414 https://curecurrent.com/trials/multi-channel-automated-diet-and-physical-activity-intervention-for-pre-diabetics-5415 https://curecurrent.com/trials/safety-and-efficacy-of-biphasic-remogliflozin-etabonate-in-the-treatment-of-type-2-diabetes-5416 https://curecurrent.com/trials/raspberries-and-postprandial-metabolism-5417 https://curecurrent.com/trials/study-to-investigate-the-pathophysiology-of-type-2-diabetes-in-youth-5418 https://curecurrent.com/trials/comparison-of-sar342434-to-humalog-as-the-rapid-acting-insulin-in-adult-patients-with-type-2-diabetes-mellitus-also-usin-5419 https://curecurrent.com/trials/effect-of-pioglitazone-and-exenatide-on-body-weight-and-beta-cell-function-5420 https://curecurrent.com/trials/restoration-of-retinal-vascular-responses-in-type-1-diabetic-patients-5421 https://curecurrent.com/trials/measurement-of-glucose-metabolism-in-humans-using-magnetic-resonance-at-4-tesla-substudy-hypoglycemia-unawareness-5422 https://curecurrent.com/trials/an-extension-protocol-to-evaluate-dose-comparisons-of-leucine-metformin-combinations-in-type-2-diabetic-patients-5424 https://curecurrent.com/trials/abate-follow-up-study-5425 https://curecurrent.com/trials/effect-of-a-medium-chain-triglyceride-supplemented-diet-on-cognitive-function-and-brain-activation-in-type-1-diabetes-5426 https://curecurrent.com/trials/registry-trial-of-the-effectiveness-of-platelet-rich-plasma-for-chronic-non-healing-wounds-5427 https://curecurrent.com/trials/adding-liraglutide-to-high-dose-insulin-breaking-the-cycle-5428 https://curecurrent.com/trials/an-inpatient-performance-evaluation-of-a-new-subcutaneous-glucose-sensor-5429 https://curecurrent.com/trials/epigenetics-and-the-origin-of-muscle-insulin-resistance-in-humans-5430 https://curecurrent.com/trials/nociceptive-pain-fiber-response-5431 https://curecurrent.com/trials/a-study-of-lgd-6972-in-patients-with-type-2-diabetes-mellitus-5432 https://curecurrent.com/trials/freestyle-libre-flash-accuracy-study-5433 https://curecurrent.com/trials/the-effect-of-exenatide-compared-to-lantus-insulin-on-vascular-function-in-type-2-diabetes-5434 https://curecurrent.com/trials/dts-blood-glucose-monitor-system-surveillance-program-substudy-1-5435 https://curecurrent.com/trials/cbt-for-adherence-and-depression-in-diabetes-5436 https://curecurrent.com/trials/utilizing-off-the-shelf-technology-to-improve-diabetes-management-in-a-rural-population-5437 https://curecurrent.com/trials/diabetes-group-prenatal-care-5438 https://curecurrent.com/trials/treatment-differences-between-canagliflozin-and-placebo-in-insulin-secretion-in-subjects-with-type-2-diabetes-mellitus-t-5439 https://curecurrent.com/trials/comparative-study-of-implant-surfaces-to-enhance-stabilization-in-patients-with-type-2-diabetes-5440 https://curecurrent.com/trials/heart-rate-variability-in-response-to-metformin-challenge-5441 https://curecurrent.com/trials/point-of-care-glucose-testing-and-insulin-supplementation-5442 https://curecurrent.com/trials/intensive-glycemic-control-for-congestive-heart-failure-exacerbation-5443 https://curecurrent.com/trials/effect-of-liraglutide-on-body-weight-in-overweight-or-obese-subjects-with-type-2-diabetes-scale-diabetes-5444 https://curecurrent.com/trials/tau-pet-imaging-in-northern-manhattan-study-of-metabolism-and-mind-5445 https://curecurrent.com/trials/omega-3-fa-supplements-as-augmentation-in-the-treatment-of-depression-5446 https://curecurrent.com/trials/role-of-pancreatic-triglyceride-content-in-beta-cell-function-5447 https://curecurrent.com/trials/oct-screening-for-diabetic-macular-edema-at-primary-diabetes-care-visits-5448 https://curecurrent.com/trials/comparing-strategies-for-translating-self-management-support-into-primary-care-5449 https://curecurrent.com/trials/economic-outcomes-of-eqw-exenatide-once-weekly-vs-ig-insulin-glargine-in-t2d-patients-who-are-new-to-injectable-therapy-5450 https://curecurrent.com/trials/impact-of-patient-activation-and-engagement-on-patient-centered-outcomes-of-care-in-acos-5451 https://curecurrent.com/trials/role-of-slowly-digesible-starch-on-diabetes-risk-factors-5452 https://curecurrent.com/trials/the-metabolic-effects-of-short-term-walnut-consumption-in-subjects-with-the-metabolic-syndrome-5453 https://curecurrent.com/trials/preservation-of-beta-cell-function-in-type-2-diabetes-mellitus-5454 https://curecurrent.com/trials/three-approaches-to-glucose-monitoring-in-non-insulin-treated-diabetes-5455 https://curecurrent.com/trials/changes-in-ectopic-fat-following-surgically-induced-weight-loss-5456 https://curecurrent.com/trials/pioglitazone-on-pancreatic-steatosis-and-bone-health-5458 https://curecurrent.com/trials/open-label-study-in-diabetic-foot-ulcers-dfu-to-evaluate-safety-of-0-03-dsc127-topical-gel-in-chronic-use-5459 https://curecurrent.com/trials/effect-of-closed-loop-glucose-control-on-exercise-associated-hypoglycemia-5460 https://curecurrent.com/trials/inpatient-closed-loop-glucose-control-5461 https://curecurrent.com/trials/treatment-of-diabetes-and-depression-in-hispanics-and-african-americans-and-its-effect-on-a1c-and-quality-of-life-5462 https://curecurrent.com/trials/phase-iii-study-to-evaluate-efficacy-and-safety-of-dsc127-in-diabetic-foot-ulcers-5463 https://curecurrent.com/trials/phase-3-study-evaluating-efficacy-and-safety-of-dsc127-compared-with-vehicle-and-with-standard-of-care-in-diabetic-foot-5464 https://curecurrent.com/trials/the-relationship-of-hemoglobin-a1c-and-diabetic-wound-healing-5465 https://curecurrent.com/trials/vitamin-d-supplementation-on-cardiovascular-risk-factors-5466 https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-camicinal-on-gastroparesis-symptoms-in-type-1-and-2-diabetic-subjects-with-gastropares-5467 https://curecurrent.com/trials/targeting-inflammation-using-salsalate-for-type-2-diabetes-stage-ii-5468 https://curecurrent.com/trials/pioglitazone-as-a-treatment-for-lipid-and-glucose-abnormalities-in-patients-with-schizophrenia-5469 https://curecurrent.com/trials/ticagrelor-versus-clopidogrel-in-type-2-diabetic-patients-5470 https://curecurrent.com/trials/evaluation-of-the-gestational-diabetes-self-management-education-program-and-quality-improvement-plan-5471 https://curecurrent.com/trials/randomized-trial-to-evaluate-the-effectiveness-of-nurse-case-management-5472 https://curecurrent.com/trials/dose-ranging-study-in-treatment-naive-type-2-diabetes-mellitus-t2dm-5473 https://curecurrent.com/trials/direct-renin-inhibition-effects-on-atherosclerotic-biomarkers-5474 https://curecurrent.com/trials/phase-iv-study-to-evaluate-the-efficacy-of-amnioexcel-in-diabetic-foot-ulcers-5475 https://curecurrent.com/trials/a-study-with-primatrix-dermal-repair-scaffold-for-the-treatment-of-diabetic-foot-ulcers-5476 https://curecurrent.com/trials/dss-diabetes-surgery-study-intensive-medical-management-of-type-2-diabetes-with-and-without-gastric-bypass-surgery-5477 https://curecurrent.com/trials/study-of-islet-transplantation-in-type-1-diabetic-kidney-transplant-recipients-5478 https://curecurrent.com/trials/diabetes-study-with-rosiglitazone-monotherapy-versus-metformin-or-glyburide-glibenclamide-5479 https://curecurrent.com/trials/norepinephrine-and-vasopressin-versus-norepinephrine-alone-in-critically-ill-patients-with-septic-shock-5480 https://curecurrent.com/trials/molecular-regulation-of-muscle-glucose-metabolism-5481 https://curecurrent.com/trials/real-time-continuous-glucose-monitoring-5482 https://curecurrent.com/trials/acute-effect-of-exenatide-on-brain-glucose-metabolism-5483 https://curecurrent.com/trials/safety-and-effects-of-autologous-adipose-derived-stromal-cells-delivered-in-patients-with-type-ii-diabetes-5484 https://curecurrent.com/trials/a-multicenter-study-of-outpatient-automated-blood-glucose-control-with-a-bihormonal-bionic-pancreas-5485 https://curecurrent.com/trials/cardiovascular-outcomes-in-participants-with-type-2-diabetes-mellitus-t2dm-5486 https://curecurrent.com/trials/is-a-smartphone-application-effective-as-an-oral-medication-adherence-aid-5487 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pk-and-pd-of-da-1241-in-healthy-male-subjects-5488 https://curecurrent.com/trials/exercise-to-reduce-obesity-in-spinal-cord-injury-5489 https://curecurrent.com/trials/effects-of-web-based-health-information-on-risk-behavior-for-youth-with-type-1-diabetes-in-college-5490 https://curecurrent.com/trials/integration-of-continuous-glucose-monitoring-into-a-bihormonal-closed-loop-artificial-pancreas-5491 https://curecurrent.com/trials/a-phase-1-study-to-evaluate-hti-2088-tablet-5492 https://curecurrent.com/trials/trx4-monoclonal-antibody-in-type-1-diabetes-t1-dm-5493 https://curecurrent.com/trials/extended-follow-up-after-islet-transplantation-in-t1d-5494 https://curecurrent.com/trials/simplified-insulin-protocol-using-lantus-in-elderly-5495 https://curecurrent.com/trials/protein-amino-acids-insulin-glucagon-secretion-in-humans-5496 https://curecurrent.com/trials/feasibility-and-efficacy-of-delivering-blood-glucose-awareness-training-over-the-internet-5497 https://curecurrent.com/trials/biospecimens-for-identification-of-diseases-of-the-pancreas-5498 https://curecurrent.com/trials/obstructive-sleep-apnea-osa-sleepiness-and-activity-in-diabetes-management-5499 https://curecurrent.com/trials/a-first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-hm12460a-5500 https://curecurrent.com/trials/diabetic-shoulder-mobility-5501 https://curecurrent.com/trials/relationship-between-hba1c-and-chronic-glycemia-in-patients-with-cirrhosis-5502 https://curecurrent.com/trials/effect-of-weight-bearing-exercise-on-people-with-diabetes-and-neuropathic-feet-5503 https://curecurrent.com/trials/risk-assessment-of-long-haul-truck-drivers-5504 https://curecurrent.com/trials/an-evaluation-of-an-sccd-on-the-symptomatology-of-painful-dpn-5505 https://curecurrent.com/trials/vasopressin-effects-on-human-social-communication-5506 https://curecurrent.com/trials/egg-ingestion-in-adults-with-type-2-diabetes-5507 https://curecurrent.com/trials/a-study-investigating-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk2330672-administered-with-metformi-5508 https://curecurrent.com/trials/multiple-ascending-dose-study-of-hm12470-in-type-1-and-type-2-diabetes-mellitus-5509 https://curecurrent.com/trials/accu-chek-connect-personal-diabetes-management-study-pdm-connect-5510 https://curecurrent.com/trials/behavioral-activation-therapy-for-rural-veterans-with-diabetes-and-depression-5511 https://curecurrent.com/trials/a-trial-evaluating-compatibility-and-safety-of-fiasp-and-insulin-aspart-with-an-external-continuous-subcutaneous-insulin-5512 https://curecurrent.com/trials/dose-ranging-study-in-subjects-with-type-2-diabetes-mellitus-who-are-treatment-naive-5513 https://curecurrent.com/trials/molecular-regulation-of-muscle-glucose-metabolism-aims-2a-2b-3-5514 https://curecurrent.com/trials/the-efficacy-of-insulin-degludec-liraglutide-as-add-on-therapy-in-controlling-glycaemia-in-adults-with-type-2-diabetes-i-5515 https://curecurrent.com/trials/pgc-1-muscle-mitochondrial-dysfunction-in-diabetes-aims-1-4-5516 https://curecurrent.com/trials/wine-consumption-and-glycemic-control-5517 https://curecurrent.com/trials/closed-loop-glucose-control-for-automated-management-of-type-1-diabetes-5518 https://curecurrent.com/trials/raptiva-and-sirolimus-in-islet-transplantation-for-type-1-diabetes-5519 https://curecurrent.com/trials/enhancing-informal-caregiving-to-support-diabetes-self-management-5520 https://curecurrent.com/trials/diabetic-ketoacidosis-brain-morphology-and-cognition-5521 https://curecurrent.com/trials/a-study-of-ly2963016-compared-to-lantus-in-adult-participants-with-type-2-diabetes-mellitus-5522 https://curecurrent.com/trials/effects-of-kdt501-on-metabolic-features-in-insulin-resistant-subjects-5523 https://curecurrent.com/trials/efficacy-of-islet-after-kidney-transplantation-5524 https://curecurrent.com/trials/the-summer-camp-study-2-blood-glucose-control-with-a-bi-hormonal-endocrine-pancreas-5525 https://curecurrent.com/trials/improving-outcomes-in-underserved-women-with-gdm-5526 https://curecurrent.com/trials/effects-of-continuous-positive-airway-pressure-cpap-on-glucose-metabolism-5527 https://curecurrent.com/trials/family-weight-management-study-5528 https://curecurrent.com/trials/dream-project-community-health-worker-intervention-5529 https://curecurrent.com/trials/fatty-acid-metabolism-and-insulin-sensitivity-the-role-of-endurance-exercise-5530 https://curecurrent.com/trials/efficacy-and-safety-of-artacent-for-treatment-resistant-lower-extremity-venous-and-diabetic-ulcers-5532 https://curecurrent.com/trials/call-2-health-preventing-type-ii-diabetes-5533 https://curecurrent.com/trials/effects-of-canagliflozin-on-intravascular-volume-and-hemodynamics-5534 https://curecurrent.com/trials/differential-metabolism-of-dietary-fatty-acids-5535 https://curecurrent.com/trials/a-study-of-gsk256073-in-subjects-with-type-2-diabetes-mellitus-who-are-being-treated-with-metformin-5536 https://curecurrent.com/trials/mobile-communication-technology-for-adolescents-with-diabetes-5537 https://curecurrent.com/trials/a-study-to-assess-the-safety-of-single-doses-of-gsk189075-in-subjects-with-type-1-diabetes-mellitus-5538 https://curecurrent.com/trials/magnetic-resonance-angiography-to-diagnose-atherosclerotic-disease-5539 https://curecurrent.com/trials/immunosuppression-impact-on-the-metabolic-control-of-kidney-transplant-with-pre-existing-type-2-diabetes-dm-5540 https://curecurrent.com/trials/evaluation-of-single-nucleotide-polymorphisms-snps-in-patients-with-and-without-diabetic-macular-edema-5541 https://curecurrent.com/trials/impact-inactivity-monitoring-and-physical-activity-controlled-trial-5542 https://curecurrent.com/trials/families-on-track-a-digital-health-behavioral-intervention-for-parents-seeking-treatment-for-their-child-with-obesity-5543 https://curecurrent.com/trials/improving-outcomes-for-individuals-with-serious-mental-illness-and-diabetes-5544 https://curecurrent.com/trials/trial-of-otelixizumab-for-adults-with-newly-diagnosed-type-1-diabetes-mellitus-autoimmune-defend-1-5545 https://curecurrent.com/trials/evaluating-the-effect-of-aliskiren-versus-hctz-on-coronary-flow-reserve-in-hypertensive-type-ii-diabetics-5546 https://curecurrent.com/trials/medtronic-treat-to-range-ttr-closed-loop-control-5547 https://curecurrent.com/trials/comparison-of-neutral-protamine-hagedorn-nph-and-lantus-based-insulin-regimen-in-the-management-of-hypoglycemia-in-the-h-5548 https://curecurrent.com/trials/in-clinic-evaluation-of-the-plgm-feature-5549 https://curecurrent.com/trials/computer-based-intervention-for-type-2-diabetes-in-youth-5550 https://curecurrent.com/trials/study-of-clonidine-hydrochloride-topical-gel-0-1-in-the-treatment-of-pain-associated-with-diabetic-neuropathy-5551 https://curecurrent.com/trials/metformin-at-the-cellular-level-and-dosing-for-diabetes-mellitus-dm-5552 https://curecurrent.com/trials/biological-basis-of-individual-variation-in-social-cooperation-5553 https://curecurrent.com/trials/the-effect-of-insulin-degludec-in-combination-with-liraglutide-and-metformin-in-subjects-with-type-2-diabetes-qualifying-5554 https://curecurrent.com/trials/circuit-training-and-motivational-interviewing-to-reduce-type-2-diabetes-in-youth-5555 https://curecurrent.com/trials/pilot-study-assessing-insulin-pump-therapy-in-type-2-diabetes-5556 https://curecurrent.com/trials/exhaled-carbon-monoxide-and-red-blood-cell-turnover-5557 https://curecurrent.com/trials/the-efficacy-and-safety-of-clonidine-hydrochloride-topical-gel-vs-clonidine-hydrochloride-gel-comparator-to-treat-painfu-5558 https://curecurrent.com/trials/a-safety-study-of-clonidine-hydrochloride-topical-gel-0-1-in-the-treatment-of-painful-diabetic-neuropathy-5559 https://curecurrent.com/trials/computer-based-screening-for-diabetic-retinopathy-5560 https://curecurrent.com/trials/combination-therapy-with-sitagliptin-and-lansoprazole-to-restore-pancreatic-beta-cell-function-in-recent-onset-type-1-di-5561 https://curecurrent.com/trials/reducing-total-cardiovascular-risk-in-an-urban-community-5562 https://curecurrent.com/trials/social-forces-to-improve-statin-adherence-study-a-5563 https://curecurrent.com/trials/preservation-of-pancreatic-beta-cell-function-through-insulin-pump-therapy-5564 https://curecurrent.com/trials/effects-of-statins-on-lower-extremity-arterial-function-assessed-by-magnetic-resonance-imaging-5565 https://curecurrent.com/trials/medtronic-minimed-implantable-insulin-pump-5566 https://curecurrent.com/trials/effect-of-gsk376501-on-cyp450-activity-in-healthy-adult-subjects-5567 https://curecurrent.com/trials/healthy-io-method-comparison-user-performance-study-5568 https://curecurrent.com/trials/injection-site-study-in-patients-with-type-2-diabetes-mellitus-t2dm-and-healthy-volunteers-5569 https://curecurrent.com/trials/the-effect-of-exenatide-on-weight-and-hunger-in-obese-healthy-women-5570 https://curecurrent.com/trials/the-summer-camp-study-blood-glucose-control-with-a-bi-hormonal-bionic-endocrine-pancreas-5571 https://curecurrent.com/trials/first-time-in-humans-study-to-assess-safety-pharmacokinetics-pharmacodynamics-of-sb756050-5572 https://curecurrent.com/trials/a-study-to-assess-the-safety-and-tolerability-of-gsk189075-when-given-with-a-total-daily-dose-of-2000mg-of-metformin-5573 https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-accuracy-5574 https://curecurrent.com/trials/egg-consumption-and-glycemic-control-in-individuals-with-pre-and-type-ii-diabetes-5575 https://curecurrent.com/trials/calorie-restriction-and-changes-in-body-composition-disease-function-and-quality-of-life-in-older-adults-5576 https://curecurrent.com/trials/metformin-s-effect-on-glucagon-induced-glucose-production-and-protein-metabolism-5577 https://curecurrent.com/trials/metformin-for-weight-loss-in-schizophrenia-5578 https://curecurrent.com/trials/effect-of-ethanol-intoxication-on-the-anti-hypoglycemic-action-of-glucagon-5579 https://curecurrent.com/trials/schizophrenia-antipsychotic-treatment-and-the-risk-for-diabetes-mellitus-5580 https://curecurrent.com/trials/evaluation-of-an-ascensia-blood-glucose-meter-and-app-system-5581 https://curecurrent.com/trials/dhacm-mesh-in-the-treatment-of-diabetic-foot-ulcers-5582 https://curecurrent.com/trials/encourage-healthy-families-5583 https://curecurrent.com/trials/diabetes-prevention-translation-the-healthy-lifestyle-project-5584 https://curecurrent.com/trials/families-preventing-diabetes-together-5585 https://curecurrent.com/trials/a-study-to-assess-the-safety-of-repeated-doses-of-gsk189075-and-wellbutrin-sr-in-healthy-male-subjects-5586 https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-dexcom-g4-platinum-with-modified-algorithm-5587 https://curecurrent.com/trials/advanced-medical-therapy-versus-advanced-medical-therapy-plus-bariatric-surgery-for-the-resolution-of-type-2-diabetes-5588 https://curecurrent.com/trials/risk-of-diabetes-in-young-turner-syndrome-patients-5589 https://curecurrent.com/trials/avastin-for-pdr-proliferative-diabetic-retinopathy-5590 https://curecurrent.com/trials/pediatrics-owning-performance-study-5591 https://curecurrent.com/trials/scintigraphy-study-to-assess-gastric-emptying-in-healthy-subjects-given-gsk716155-or-placebo-5592 https://curecurrent.com/trials/study-to-investigate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk2330672-in-type-2-diabetes-patients-5593 https://curecurrent.com/trials/a-study-to-evaluate-the-food-effect-on-drug-availability-pharmacokinetic-pk-properties-safety-and-tolerability-of-two-di-5594 https://curecurrent.com/trials/diet-and-systemic-inflammation-5595 https://curecurrent.com/trials/adverse-effects-of-systemic-hypoglycemia-exposure-on-endothelial-function-in-humans-5596 https://curecurrent.com/trials/diabetes-scorecard-educational-intervention-study-5597 https://curecurrent.com/trials/vasopressin-and-the-social-brain-5598 https://curecurrent.com/trials/use-of-sitagliptin-to-decrease-microalbuminuria-5599 https://curecurrent.com/trials/dose-effect-of-ssr180575-in-diabetic-neuropathy-5600 https://curecurrent.com/trials/a-12-week-study-to-evaluate-pf-06291874-once-a-day-in-adults-with-t2dm-inadequately-controlled-on-metformin-5601 https://curecurrent.com/trials/study-to-determine-the-utility-of-novel-technologies-and-biomarkers-to-measure-human-response-to-rosiglitazone-maleate-5602 https://curecurrent.com/trials/active-and-healthy-brotherhood-a-program-for-chronic-disease-self-management-for-black-men-5603 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-metformin-in-patients-with-type-2-diabetes-5604 https://curecurrent.com/trials/a-helping-hand-among-low-income-patients-5605 https://curecurrent.com/trials/diabetes-care-transformation-diabetes-data-registry-and-intensive-remote-monitoring-5606 https://curecurrent.com/trials/multi-tracer-pet-quantitation-of-insulin-action-5607 https://curecurrent.com/trials/closed-loop-insulin-pump-therapy-after-islet-auto-transplantation-5608 https://curecurrent.com/trials/skeletal-muscle-lipid-and-insulin-resistance-effects-of-physical-activity-and-weight-loss-5609 https://curecurrent.com/trials/reproducibility-of-hba1c-measurement-on-the-aina-hba1c-monitoring-system-5610 https://curecurrent.com/trials/dietary-nitrate-and-exercise-to-augment-exercise-training-benefits-in-subjects-with-dm-pad-5611